The proposed method showed high level of analytical sensitivity as well as specificity and it could potentially be used for the detection of PCA3. Moreover, this methodology could differentiate PCa patients from both healthy controls and BPH patients based on PCA3 level in urine. Here, PCA3 is linked to benign prostatic hyperplasia.